Research suggests a very limited and methodologically weak evidence base for devil's claw as a pain relief intervention based on the studies provided here. The available literature consists of a retrospective post-marketing surveillance study and a single case report, neither of which constitutes the rigorous controlled trial evidence typically needed to draw firm conclusions about effectiveness. The retrospective study offered mixed findings, noting that psychological and social factors significantly influenced outcomes and that some patients may not respond to the supplement at all, while the case report involved devil's claw as just one component of a multi-therapy regimen in a single patient, making it impossible to attribute any observed pain relief to devil's claw specifically. Studies indicate that while some patients in observational contexts have reported benefit, the current body of evidence reviewed here is far too limited in scope and study design to support broad conclusions about devil's claw as a reliable pain management option.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Retrospective evaluation of biopsychosocial determinants and treatment respon... | Other | 2009 | Mixed | 100 |
| [Bone metastases in breast carcinoma]. | Other | 2006 | Mixed | 95 |